Physiologic Nrf1 delays MASLD progression, Nrf2 induction alleviates MASH, and combined enhancement synergistically protects against steatosis and may facilitate liver repair. Here, NFE2L2 is linked to metabolic dysfunction-associated steatotic liver disease.